{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:15:15Z","timestamp":1779905715501,"version":"3.53.1"},"reference-count":60,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Animals"],"abstract":"<jats:p>Background: Myxomatous mitral valve degeneration is the most common canine heart disease. Several clinical trials have investigated various treatments. The latest recommendations are published in the ACVIM consensus guidelines (2019). Our study aimed to investigate how closely veterinary practitioners apply the treatment recommendations of these guidelines and the latest clinical trials. Methods: An online survey was sent to Dutch and Belgian veterinary practices via digital channels. Results: The data from 363 fully completed surveys were analyzed. For stage B1 disease, 93% recommended, correctly, no treatment. For stage B2 disease, 67% of the respondents recommended starting pimobendan as monotherapy. For chronic treatment of stage C disease, 16 different drug combinations were mentioned, but nobody recommended surgery. Only 48% of the respondents recommended the only evidence-based drug combination: a loop diuretic with pimobendan. A concerning finding was the simultaneous prescription of two loop diuretics, by 19% of the respondents. Conclusions: Treatment recommendations showed an increasing variation with more advanced disease stages from B1 through B2 to C. This reflects the increasing disagreement among the panelists who prepared the ACVIM consensus guidelines. Practitioners of our study seem to practice more evidence-based medicine than veterinary cardiologists, as it was reported in a recent survey-based study.<\/jats:p>","DOI":"10.3390\/ani14050772","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T07:36:21Z","timestamp":1709278581000},"page":"772","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Self-Reported Utilization of International (ACVIM Consensus) Guidelines and the Latest Clinical Trial Results on the Treatment of Dogs with Various Stages of Myxomatous Mitral Valve Degeneration: A Survey among Veterinary Practitioners"],"prefix":"10.3390","volume":"14","author":[{"given":"Marie D. B.","family":"van Staveren","sequence":"first","affiliation":[{"name":"Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CM Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Muis","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CM Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-6586","authenticated-orcid":false,"given":"Viktor","family":"Szatm\u00e1ri","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 108, 3584 CM Utrecht, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jvc.2012.01.011","article-title":"Historical review, epidemiology and natural history of degenerative mitral valve disease","volume":"14","author":"Borgarelli","year":"2012","journal-title":"J. Vet. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/jvim.15251","article-title":"Prognostic factors in dogs with presumed degenerative mitral valve disease attending primary-care veterinary practices in the United Kingdom","volume":"33","author":"Mattin","year":"2018","journal-title":"J. Vet. Intern. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/jsap.12265","article-title":"Murmur intensity in small-breed dogs with myxomatous mitral valve disease reflects disease severity","volume":"55","author":"Ljungvall","year":"2014","journal-title":"J. Small Anim. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/jvim.15488","article-title":"ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs","volume":"33","author":"Keene","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jvc.2020.11.005","article-title":"Predictors of reoccurrence of congestive signs within 180 days after successful treatment of the first episode of congestive heart failure in dogs with myxomatous mitral valve disease","volume":"34","author":"Franchini","year":"2021","journal-title":"J. Vet. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.cvsm.2022.01.010","article-title":"Asymptomatic canine degenerative valve disease: Diagnosis and current and future therapies","volume":"52","author":"Gordon","year":"2022","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1939-1676.2007.0008.x","article-title":"Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease","volume":"22","author":"Borgarelli","year":"2008","journal-title":"J. Vet. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/jvim.14586","article-title":"Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: The EPIC study\u2014A randomized clinical trial","volume":"30","author":"Boswood","year":"2016","journal-title":"J. Vet. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/jvim.14885","article-title":"Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with preclinical myxomatous mitral valve disease receiving pimobendan or placebo: The EPIC study","volume":"32","author":"Boswood","year":"2018","journal-title":"J. Vet. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jvc.2019.12.002","article-title":"DELay of appearance of symptoms of canine degenerative mitral valve disease treated with spironolactone and benazepril: The DELAY study","volume":"27","author":"Borgarelli","year":"2020","journal-title":"J. Vet. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1939-1676.2002.tb01610.x","article-title":"Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation","volume":"16","author":"Kvart","year":"2002","journal-title":"J. Vet. Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2460\/javma.231.7.1061","article-title":"Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency","volume":"231","author":"Atkins","year":"2007","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1939-1676.2009.0467.x","article-title":"Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease","volume":"24","author":"Bernay","year":"2010","journal-title":"J. Vet. Intern. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1939-1676.2008.0150.x","article-title":"Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: The QUEST study","volume":"22","author":"Boswood","year":"2008","journal-title":"J. Vet. Intern. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"BENCH (BENazepril in Canine Heart disease) Study Group, Pouchelon, J.L., King, J., Martignoni, L., Chetboul, V., Lugardon, B., Rousselot, J.F., Corlouer, J.P., Bussadori, C., and Piette, M.H. (1999). The Effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J. Vet. Cardiol., 1, 7\u201318.","DOI":"10.1016\/S1760-2734(06)70025-X"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1939-1676.1995.tb01074.x","article-title":"Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: Results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study: The IMPROVE Study Group","volume":"9","author":"Sisson","year":"1995","journal-title":"J. Vet. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/jvim.15864","article-title":"Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study","volume":"34","author":"Besche","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1111\/jvim.15863","article-title":"Efficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial","volume":"34","author":"Wess","year":"2020","journal-title":"J. Vet. Intern. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/jvim.16155","article-title":"Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)","volume":"35","author":"Coffman","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jvc.2012.01.003","article-title":"Effect of torsemide and furosemide on clinical, laboratory, radiographic and quality of life variables in dogs with heart failure secondary to mitral valve disease","volume":"14","author":"Peddle","year":"2012","journal-title":"J. Vet. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"BENCH (BENazepril in Canine Heart disease) Study Group, Pouchelon, J.L., King, J., Martignoni, L., Chetboul, V., Lugardon, B., Rousselot, J.F., Corlouer, J.P., Bussadori, C., and Piette, M.H. (2004). Long-term tolerability of benazepril in dogs with congestive heart failure. J. Vet. Cardiol., 6, 7\u201313.","DOI":"10.1016\/S1760-2734(06)70059-5"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2460\/javma.1998.213.11.1573","article-title":"Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group","volume":"213","author":"Ettinger","year":"1998","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2460\/javma.258.6.638","article-title":"Left atrial decompression as a palliative minimally invasive treatment for congestive heart failure caused by myxomatous mitral valve disease in dogs: 17 cases (2018\u20132019)","volume":"258","author":"Allen","year":"2021","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1939-1676.2009.0392.x","article-title":"Guidelines for the diagnosis and treatment of canine chronic valvular heart disease","volume":"23","author":"Atkins","year":"2009","journal-title":"J. Vet. Intern. Med."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"van Staveren, M.D.B., Muis, E., and Szatm\u00e1ri, V. (2023). Self-reported utilization of international guidelines for staging dogs with myxomatous mitral valve degeneration: A survey among veterinary practitioners. Vet. Sci., 10.","DOI":"10.3390\/vetsci10120687"},{"key":"ref_26","unstructured":"van Vuuren, D., Vlaanderen, M., Pomp, M., and Geelen, J. (2024, January 04). SEO Arbeidsmarkt Dierenartsen. Available online: www.seo.nl."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2460\/javma.1995.206.02.194","article-title":"Vertebral scale system to measure canine heart size in radiographs","volume":"206","author":"Buchanan","year":"1995","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2460\/javma.253.8.1038","article-title":"Diagnostic value of vertebral left atrial size as determined from thoracic radiographs for assessment of left atrial size in dogs with myxomatous mitral valve disease","volume":"253","author":"Malcolm","year":"2018","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jvc.2021.07.003","article-title":"Prediction of clinically important acquired cardiac disease without an echocardiogram in large breed dogs using a combination of clinical, radiographic and electrocardiographic variables","volume":"40","author":"Wesselowski","year":"2022","journal-title":"J. Vet. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/jvim.16083","article-title":"Accuracy of history, physical examination, cardiac biomarkers, and biochemical variables in identifying dogs with stage B2 degenerative mitral valve disease","volume":"35","author":"Wilshaw","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1939-1676.2011.00842.x","article-title":"Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease","volume":"26","author":"Rasmussen","year":"2012","journal-title":"J. Vet. Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"105704","DOI":"10.1016\/j.tvjl.2021.105704","article-title":"Short-term heart rate variability in healthy dogs and dogs in various stages of degenerative mitral valve disease evaluated before pharmacotherapy","volume":"274","author":"Baisan","year":"2021","journal-title":"Vet. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1748-5827.1996.tb01941.x","article-title":"Heart rate variability in relation to severity of mitral regurgitation in Cavalier King Charles spaniels","volume":"37","author":"Hamlin","year":"1996","journal-title":"J. Small Anim. Pract."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/jvim.15566","article-title":"Clinical and laboratory findings and survival time associated with cardiac cachexia in dogs with congestive heart failure","volume":"33","author":"Ineson","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1939-1676.1995.tb03276.x","article-title":"Heart sounds and murmurs: Changes related to severity of chronic valvular disease in the Cavalier King Charles spaniel","volume":"9","author":"Kvart","year":"1995","journal-title":"J. Vet. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/vru.12949","article-title":"Evaluation of radiographic predictors of left heart enlargement in dogs with known or suspected cardiovascular disease","volume":"62","author":"Duler","year":"2021","journal-title":"Vet. Radiol. Ultrasound"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/jvim.16918","article-title":"Utility of vertebral left atrial size and vertebral heart size to aid detection of congestive heart failure in dogs with respiratory signs","volume":"37","author":"Ross","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"ref_38","first-page":"359","article-title":"Confidence and competence of recent veterinary graduates\u2014Is there a problem?","volume":"44","author":"Lofstedt","year":"2003","journal-title":"Can. Vet. J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jvc.2021.11.003","article-title":"Analysis of canine cardiovascular therapeutic agent prescriptions using electronic health records in primary care veterinary practices in the United Kingdom","volume":"39","author":"Bode","year":"2022","journal-title":"J. Vet. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Klein, S., Nolte, I., Rumstedt, K., Sehn, M., Raue, J.F., Weiner, F., Treese, J.S., Beyerbach, M., and Bach, J.-P. (2021). The effect of treatment with pimobendan in dogs with preclinical mitral valve disease\u2014A placebo-controlled double-blinded crossover study. BMC Vet. Res., 17.","DOI":"10.1186\/s12917-021-03014-5"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/jvim.16796","article-title":"Effect of a specially formulated diet on progression of heart enlargement in dogs with subclinical degenerative mitral valve disease","volume":"37","author":"Oyama","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.2460\/javma.22.07.0280","article-title":"Whole blood and plasma taurine reference intervals in adult Cavalier King Charles Spaniels and correlations between taurine concentration, diet and mitral valve disease","volume":"260","author":"Wesselowski","year":"2022","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1939-1676.2007.tb03016.x","article-title":"Comparative adverse cardiac effects of pimobendan and benazepril monotherapy in dogs with mild degenerative mitral valve disease: A prospective, controlled, blinded, and randomized study","volume":"21","author":"Chetboul","year":"2007","journal-title":"J. Vet. Intern. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jvc.2022.02.001","article-title":"The Longitudinal Outcome Of canine (K9) myxomatous Mitral valve disease (LOOK-Mitral) registry: Baseline treatment characteristics","volume":"41","author":"Franchini","year":"2022","journal-title":"J. Vet. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/jsap.13461","article-title":"Angiotensin-converting enzyme inhibitors in preclinical myxomatous mitral valve disease in dogs: Systematic review and meta-analysis","volume":"63","author":"Donati","year":"2022","journal-title":"J. Small Anim. Pract."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jvim.16687","article-title":"The classical and alternative circulating renin-angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease","volume":"37","author":"Hammond","year":"2023","journal-title":"J. Vet. Intern. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2460\/ajvr.1996.57.11.1645","article-title":"Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation","volume":"57","author":"Hansson","year":"1996","journal-title":"Am. J. Vet. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jvim.15454","article-title":"The renin-angiotensin-aldosterone system and its suppression","volume":"33","author":"Ames","year":"2019","journal-title":"J. Vet. Intern. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1939-1676.2010.0622.x","article-title":"Letter to the editor","volume":"24","author":"Kittleson","year":"2010","journal-title":"J. Vet. Intern. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jvc.2017.03.001","article-title":"Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease","volume":"19","author":"Ames","year":"2017","journal-title":"J. Vet. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1292\/jvms.65.1057","article-title":"The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats","volume":"65","author":"Uechi","year":"2003","journal-title":"J. Vet. Med. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199834010-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of torasemide","volume":"34","author":"Knauf","year":"1998","journal-title":"Clin. Pharma"},{"key":"ref_53","unstructured":"MSD Manual (2023, December 14). Available online: https:\/\/www.msdvetmanual.com\/pharmacology\/systemic-pharmacotherapeutics-of-the-cardiovascular-system\/diuretics-for-use-in-animals."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jvim.16033","article-title":"Response to letter to the editor regarding \u201cEfficacy of adding ramipril (VAsotop) to the combination of furosemide (Lasix) and pimobendan (VEtmedin) in dogs with mitral valve degeneration: The VALVE trial\u201d","volume":"35","author":"Wess","year":"2021","journal-title":"J. Vet. Intern. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1111\/jvim.14841","article-title":"Short-term efficacy and safety of torasemide and furosemide in 366 dogs with degenerative mitral valve disease: The TEST Study","volume":"31","author":"Chetboul","year":"2017","journal-title":"J. Vet. Intern. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2460\/javma.2004.224.1941","article-title":"Evaluation of techniques and outcomes of mitral valve repair in dogs","volume":"224","author":"Griffiths","year":"2004","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2460\/javma.240.10.1194","article-title":"Mitral valve repair under cardiopulmonary bypass in small-breed dogs: 48 cases (2006\u20132009)","volume":"240","author":"Uechi","year":"2012","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jvc.2022.06.001","article-title":"The outcome of surgical mitral valve repair with loop-in-loop technique in dogs with different stage myxomatous mitral valve disease","volume":"42","author":"Matsuura","year":"2022","journal-title":"J. Vet. Cardiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.cvsm.2023.07.001","article-title":"Mitral valve repair\u2014The development and rise of options in the veterinary world","volume":"53","author":"Bristow","year":"2023","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"597879","DOI":"10.3389\/fvets.2020.597879","article-title":"Preliminary outcome of a novel edge-to-edge closure device to manage mitral regurgitation in dogs","volume":"7","author":"Liu","year":"2020","journal-title":"Front. Vet. Sci."}],"container-title":["Animals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2615\/14\/5\/772\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:07:27Z","timestamp":1760105247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2615\/14\/5\/772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["ani14050772"],"URL":"https:\/\/doi.org\/10.3390\/ani14050772","relation":{},"ISSN":["2076-2615"],"issn-type":[{"value":"2076-2615","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]}}}